# Zimmer Biomet (ZBH) — Earnings

ZBH · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/zbh/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $2.07 |
| EPS estimate | $2.01 |
| EPS surprise | +2.97% |
| Revenue surprise | +1.97% |
| Revenue | $2.2B |
| Revenue estimate | $2.1B |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1136869/000119312526335044/zbh-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/521ac9e7-c20c-9152-00be-64a708f63105.html) |

Zimmer Biomet reported Q2 2026 results on August 5, 2026. Earnings per share were $2.07, ahead of the $2.01 estimate by 2.97%. Revenue was about $2.2 billion, above the $2.1 billion consensus and the highest quarter in the table. EPS was unchanged from Q2 2025's $2.07, while revenue rose from $2.1 billion.

The longer record shows steady but slowing growth. Annual EPS rose from $6.89 in 2022 to $7.56 in 2023, $8.00 in 2024 and $8.20 in 2025. The 2025 gain was about 2.5%. The first half of 2026 adds up to $4.16, about 7% more than the first half of 2025. Q4 was the strongest quarter in every full year shown, and Q4 2025 set the table's EPS high at $2.42. Zimmer Biomet beat the EPS estimate in 18 of the last 20 quarters. The two misses, in Q4 2021 and Q3 2024, were each within about 1.3% of the estimate.

Zimmer Biomet reported Q3 results between October 30 and November 7 in each of the last five years. That points to late October or early November 2026 for the next report. It will show whether the first-half gain over 2025 holds up in Q3.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | $2.01 | $2.07 | 2.97% | $2.1B | $2.2B |
| Q1 2026 | Apr 28, 2026 | $1.87 | $2.09 | 12.05% | $2.1B | $2.1B |
| Q4 2025 | Feb 10, 2026 | $2.40 | $2.42 | 0.92% | $2.2B | $2.2B |
| Q3 2025 | Nov 5, 2025 | $1.87 | $1.90 | 1.82% | $2.0B | $2.0B |
| Q2 2025 | Aug 7, 2025 | $1.98 | $2.07 | 4.61% | $2.1B | $2.1B |
| Q1 2025 | May 5, 2025 | $1.77 | $1.81 | 2.22% | $1.9B | $1.9B |
| Q4 2024 | Feb 6, 2025 | $2.30 | $2.31 | 0.64% | $2.0B | $2.0B |
| Q3 2024 | Oct 30, 2024 | $1.74 | $1.74 | -0.22% | $1.8B | $1.8B |
| Q2 2024 | Aug 7, 2024 | $1.99 | $2.01 | 0.95% | $1.9B | $1.9B |
| Q1 2024 | May 2, 2024 | $1.87 | $1.94 | 3.72% | $1.9B | $1.9B |
| Q4 2023 | Feb 8, 2024 | $2.15 | $2.20 | 2.15% | $1.9B | $1.9B |
| Q3 2023 | Nov 7, 2023 | $1.60 | $1.65 | 3.27% | $1.7B | $1.8B |
| Q2 2023 | Aug 1, 2023 | $1.82 | $1.82 | 0.11% | $1.8B | $1.9B |
| Q1 2023 | May 2, 2023 | $1.64 | $1.89 | 15.34% | $1.7B | $1.8B |
| Q4 2022 | Feb 3, 2023 | $1.83 | $1.88 | 2.87% | $1.8B | $1.8B |
| Q3 2022 | Nov 2, 2022 | $1.55 | $1.58 | 1.66% | $1.6B | $1.7B |
| Q2 2022 | Aug 2, 2022 | $1.64 | $1.82 | 10.91% | $1.7B | $1.8B |
| Q1 2022 | Apr 28, 2022 | $1.40 | $1.61 | 14.81% | $1.6B | $1.7B |
| Q4 2021 | Feb 7, 2022 | $1.92 | $1.89 | -1.32% | $2.1B | $2.0B |
| Q3 2021 | Nov 4, 2021 | $1.70 | $1.76 | 3.06% | $1.9B | $1.9B |

## Frequently Asked Questions

### When did Zimmer Biomet (ZBH) last report earnings?

Zimmer Biomet last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did ZBH beat earnings estimates?

Yes. Zimmer Biomet reported EPS of $2.07 for Q2 2026 against a $2.01 estimate — a 2.97% beat.

### How much revenue did ZBH report last quarter?

Zimmer Biomet reported $2.2B in revenue for Q2 2026, against a consensus estimate of $2.1B.

## Similar Stocks

- [PEN](https://www.lighthorse.io/tickers/pen) — Penumbra, Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).